The stem cell banking market mainly deals with the collection, processing, and storage of adult stem cells obtained from sources such as umbilical cord blood, other cord tissue, and bone marrow. Stem cells in the banked samples can be used for treatment in cases where the patient requires a stem cell transplant. The process involves collecting and storing stem cells which are frozen and stored while maintaining their viability. Stem cell banking offers potential medical benefits in treating a variety of diseases such as cancer, blood disorders, and autoimmune diseases. As more couples opt for stem cell banking services, the prevalence of stem cell transplants has increased over time. This has propelled the need for advanced stem cell banking facilities worldwide.
The Global Stem Cell Banking Market is estimated to be valued at US$ 616.11 Mn in 2024 and is expected to exhibit a CAGR of 5.4% over the forecast period of 2024 to 2030.
Key Takeaways
Key players operating in the Global Stem Cell Banking Market Share are CM Fine Chemicals GmbH, Hawks Chemical Company, Hebei Yingong New Material Technology Co., Ltd., Heranba Industries Ltd., Jiangsu Dacheng Pharmaceutical and Chemical Co., Ltd., Luyunjia Chemistry Xiamen Limited, Merck KGaA, Mody Chemi-Pharma Limited, RX MARINE INTERNATIONAL, and Yancheng Longsheng Chemical Co., Ltd. These leading players are focusing on expanding their geographic footprint by collaborating with hospitals and research institutes in emerging economies.
The increasing incidence of chronic diseases such as cancer, blood disorders, and autoimmune diseases is expected to fuel the demand for stem cell banking services. Umbilical cord samples are the most commonly banked stem cell source due to their easy availability and suitability for transplantation.
Advancements in stem cell extraction and cryopreservation techniques have enhanced banking storage periods from a few years to decades. Companies are investing in R&D to develop innovative biological materials for optimum stem cell viability and functionality during the banking process.
Market Trends
Growing awareness regarding the therapeutic benefits of stem cells is a key trend driving the stem cell banking market. Families are more informed about stem cell banking options for future medical needs.
Another emerging trend is the automation of stem cell processing through incorporation of robotics technologies. Automation eliminates manual errors, streamlines workflows and improves stem cell storage efficiencies in banking facilities.
Market Opportunities
There is immense potential for increasing stem cell collection from additional sources such as menstrual blood, amniotic fluid, and dental pulp. Exploring alternative stem cell repositories can augment overall banking inventories.
Another opportunity lies in establishing innovative banking business models to target specific disease segments. Virtual banking through digital platforms can facilitate accessibility and affordability of stem cell therapies on a global scale.
Impact of COVID-19 on Stem Cell Banking Market Growth
The COVID-19 pandemic has had significant implications for the stem cell banking market. Stay-at-home orders and restrictions on non-essential medical procedures caused collections of new stem cell units to decline sharply during 2020. There was uncertainty around the demand and supply of stem cells needed for transplants, as hospitals diverted resources to manage COVID-19 cases. This slowed market growth in the short term. However, remote consultation services enabled some banking activities to continue. Awareness about the importance of stem cell therapy also increased as it emerged as a potential treatment option for COVID-19 related complications. Prospects are better in the post-pandemic period as elective stem cell transplants and new client signups resume. The market is also supported by ongoing approvals of novel applications of stem cells in therapeutics and regenerative medicine. Established players are expanding capabilities to store other cell types beyond cord blood. Virtual modes of customer interactions and sample collection at home are likely to sustain even after the pandemic subsides. Overall, while COVID-19 disruption was felt in 2020-2021, the long term growth outlook for this market remains positive.
The stem cell banking market in terms of value is most concentrated in North America. Presence of major industry players, superior healthcare infrastructure and higher healthcare spending have made the US and Canada dominant markets in this region. Collection and storage services are widely available. Supportive regulatory frameworks and government funding have accelerated clinical translation of stem cell research. Growing prevalence of cancer and other chronic diseases driving demand for transplantation in an aging population is a key growth driver here. Asia Pacific is projected as the fastest growing regional market. Rising medical tourism along with increased awareness, healthcare reforms and expansions by global firms see increasing numbers of families opting for stem cell storage in major Asian hubs like India, China and Japan.
Get More Insights Here
https://www.pressreleasebulletin.com/stem-cell-banking-market-size-share-growth-outlook-2023/
